Form 4: Reviva Pharmaceuticals CEO and Spouse Receive Stock Options as Incentive Bonus
SEC Form 4 Filing
Reviva Pharmaceuticals' CEO, Laxminarayan Bhat, and his spouse, Seema Bhat, were granted stock options as an incentive bonus in lieu of cash payment, according to a recent SEC Form 4 filing.
Summary
- Laxminarayan Bhat, the President and CEO of Reviva Pharmaceuticals Holdings, Inc., and his spouse, Seema Bhat, the Issuer's Vice President for Program & Portfolio Management, received stock options as an incentive bonus.
- The options were granted on September 15, 2024, by the Issuer's compensation committee in accordance with the terms of the Issuer's 2020 Equity Incentive Plan.
- Dr. Bhat received options to buy 158,451 shares of common stock at an exercise price of $1.20, expiring on September 14, 2034.
- Ms. Bhat received options to buy 77,843 shares of common stock at an exercise price of $1.20, expiring on September 14, 2034.
- The exercise price of the option award is based on the closing price of the Issuer's common stock on September 13, 2024.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, suggesting stability and alignment of interests. The sentiment is neutral to slightly positive.
Positives
- The granting of stock options to key executives aligns their interests with those of the shareholders.
- Paying the incentive bonus in the form of stock options conserves the company's cash.
Industry Context
Stock options are a common form of executive compensation in the pharmaceutical industry, aligning management's interests with shareholder value.
Comparison to Industry Standards
- Stock option grants are a standard component of executive compensation packages in the biotechnology and pharmaceutical industries.
- Companies like Amgen, Gilead Sciences, and Biogen also utilize stock options to incentivize their executives.
- The size of the grant is typical for a company of Reviva's size and stage of development.
Stakeholder Impact
- Shareholders may view the stock option grants positively as they align management's interests with increasing shareholder value.
- Employees may be motivated by the fact that executives are incentivized to improve company performance.
Key Dates
| Date | Description |
|---|---|
| 09/13/2024 | Closing price of Issuer's common stock used to determine exercise price of options. |
| 09/15/2024 | Grant date of stock options to Laxminarayan Bhat and Seema Bhat. |
| 09/14/2034 | Expiration date of stock options granted to Laxminarayan Bhat and Seema Bhat. |
| 09/17/2024 | Date of SEC filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.